The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorTurku University Hospital
About this trial
The study will assess the effect of cancer treatments on speech perception in noise, cognition, and hearing-related quality of life by monitoring 200 cancer patients receiving standard care for their underlying malignancy.
Eligibility criteria
Qualifiers
written informed consent
native Finnish speaker
age-normative hearing
for participants in the treatment arms: diagnosis of a malignancy that will be treated with curative intent with any of the following: 1) Cisplatin as the main chemotherapeutic agent, 2) oxaliplatin as the main chemotherapeutic agent, 3) cisplatin-based chemoradiation therapy in the head and neck region, 4) radiation therapy in the head and neck region
Disqualifiers
inability to provide written informed consent
Current or prior major otological condition that has affected or has had the potential to affect hearing
Conductive or asymmetric sensorineural HL of any severity
Severe sensorineural HL
Trial design
Treatments tested in this trial
- Chemotherapy, chemoradiation, radiation therapy
Treatment groups
250 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov